Zyprexa

Get a free case evaluation<<<<<<<

Zyprexa is a popular antipsychotic drug, developed and marketed by Elli Lilly. Zyprexa is used to treat a wide range of disorders including bipolarism, manic depression, anxiety, schizophrenia and other psychotic conditions.

Serious side effects linked to Zyprexa include diabetes, pancreatitis, hyperglycemia and hypoglycemia. The U.S. Food and Drug Administration (FDA) has identified over 300 reports of Zyprexa use causing diabetes, including 23 deaths. Diabetes is diagnosed with the majority of cases; within six months of the date the patient begins using Zyprexa.

In 2002, both Japan and the European Union required Eli Lilly to include an obvious diabetes-related complications warning on Zyprexa product information sheets. This measure was taken in response to dozens of cases in which patients using Zyprexa suffered injuries from changes in their blood glucose. Some patients went into diabetic comas and some even died. In 2005, the FDA requested that Eli Lilly and Company update its product labeling for Zyprexa to include a warning about hyperglycemia and diabetes. Nevertheless, the warning is far from obvious. It is buried deep in the adverse reactions section of the drug’s labeling.

Zyprexa works by inhibiting certain dopamine and serotonin receptors that are linked to schizophrenia and depression. The FDA approved Zyprexa for the treatment of schizophrenia in 1996 and for the treatment of bipolar mania in 2000. It is part of a new generation of antipsychotics known as atypicals. The primary advantage of the newer atypical antipsychotic medications was supposed to be a lower incidence of side effects than the conventional antipsychotics introduced in the 1950s.

If you believe that you or a loved one has suffered as a result of taking Zyprexa, you may want to speak with an attorney. A lawyer familiar with new developments in the investigation of Zyprexa may be able to help you make important personal and legal decisions. To fill out a confidential form, CLICK HERE.